Literature DB >> 10493592

Monomer-trimer equilibrium of the ectodomain of SIV gp41: insight into the mechanism of peptide inhibition of HIV infection.

M Caffrey1, J Kaufman, S Stahl, P Wingfield, A M Gronenborn, G M Clore.   

Abstract

The monomer-trimer equilibrium of the ectodomain of SIV gp41 (residues 27-149, e-gp41) has been characterized by analytical ultracentrifugation, circular dichroism (CD), and NMR spectroscopy. Based on analytical ultracentrifugation experiments performed at different rotor speeds and protein concentrations, the equilibrium association constant for the SIV e-gp41 trimer is 3.1 x 10(11) M(-2). The presence of intermolecular nuclear Overhauser effects in a mixture of 12C and 13C-labeled e-gp41 prepared under nondenaturing conditions unambiguously demonstrates that there is a dynamic equilibrium between the monomer and trimer. The CD spectra taken as a function of SIV e-gp41 concentration suggest that the helical content of the monomeric state does not change significantly relative to that of the trimeric state. The relevance of the monomer-trimer equilibrium is discussed with respect to gp41 function and the inhibitory properties of gp41 peptides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493592      PMCID: PMC2144406          DOI: 10.1110/ps.8.9.1904

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  15 in total

1.  A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

Authors:  M Lu; S C Blacklow; P S Kim
Journal:  Nat Struct Biol       Date:  1995-12

2.  Atomic structure of a thermostable subdomain of HIV-1 gp41.

Authors:  K Tan; J Liu; J Wang; S Shen; M Lu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

3.  Atomic structure of the ectodomain from HIV-1 gp41.

Authors:  W Weissenhorn; A Dessen; S C Harrison; J J Skehel; D C Wiley
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

4.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  Determination of the secondary structure and global topology of the 44 kDa ectodomain of gp41 of the simian immunodeficiency virus by multidimensional nuclear magnetic resonance spectroscopy.

Authors:  M Caffrey; M Cai; J Kaufman; S J Stahl; P T Wingfield; A M Gronenborn; G M Clore
Journal:  J Mol Biol       Date:  1997-09-05       Impact factor: 5.469

6.  A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein.

Authors:  S C Blacklow; M Lu; P S Kim
Journal:  Biochemistry       Date:  1995-11-21       Impact factor: 3.162

Review 7.  Determining the structures of large proteins and protein complexes by NMR.

Authors:  G M Clore; A M Gronenborn
Journal:  Trends Biotechnol       Date:  1998-01       Impact factor: 19.536

8.  The extracellular domain of immunodeficiency virus gp41 protein: expression in Escherichia coli, purification, and crystallization.

Authors:  P T Wingfield; S J Stahl; J Kaufman; A Zlotnick; C C Hyde; A M Gronenborn; G M Clore
Journal:  Protein Sci       Date:  1997-08       Impact factor: 6.725

9.  3D NMR experiments for measuring 15N relaxation data of large proteins: application to the 44 kDa ectodomain of SIV gp41.

Authors:  M Caffrey; J Kaufman; S J Stahl; P T Wingfield; A M Gronenborn; G M Clore
Journal:  J Magn Reson       Date:  1998-12       Impact factor: 2.229

10.  A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Authors:  C Wild; T Oas; C McDanal; D Bolognesi; T Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more
  19 in total

1.  Sedimentation velocity studies of the high-molecular weight aggregates of the HIV gp41 ectodomain.

Authors:  Amy Jacobs; Kari Hartman; Thomas Laue; Michael Caffrey
Journal:  Protein Sci       Date:  2004-08-31       Impact factor: 6.725

2.  Trimeric, coiled-coil extension on peptide fusion inhibitor of HIV-1 influences selection of resistance pathways.

Authors:  Min Zhuang; Wei Wang; Christopher J De Feo; Russell Vassell; Carol D Weiss
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

3.  Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation.

Authors:  Antony S Dimitrov; John M Louis; Carole A Bewley; G Marius Clore; Robert Blumenthal
Journal:  Biochemistry       Date:  2005-09-20       Impact factor: 3.162

4.  Full-length trimeric influenza virus hemagglutinin II membrane fusion protein and shorter constructs lacking the fusion peptide or transmembrane domain: Hyperthermostability of the full-length protein and the soluble ectodomain and fusion peptide make significant contributions to fusion of membrane vesicles.

Authors:  Punsisi U Ratnayake; E A Prabodha Ekanayaka; Sweta S Komanduru; David P Weliky
Journal:  Protein Expr Purif       Date:  2015-08-19       Impact factor: 1.650

5.  Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.

Authors:  Emmanuel Desmezieres; Nidhi Gupta; Russell Vassell; Yong He; Keith Peden; Lev Sirota; Zhongning Yang; Paul Wingfield; Carol D Weiss
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 6.  Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptides.

Authors:  Avraham Ashkenazi; Yechiel Shai
Journal:  Eur Biophys J       Date:  2011-01-22       Impact factor: 1.733

7.  Design and characterization of swapped-domain constructs of HIV-1 glycoprotein-41 as receptors for drug discovery.

Authors:  Joseph D Walsh; Shidong Chu; Shao-Qing Zhang; Miriam Gochin
Journal:  Protein Eng Des Sel       Date:  2015-04       Impact factor: 1.650

8.  Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Authors:  Rogier W Sanders; Mika Vesanen; Norbert Schuelke; Aditi Master; Linnea Schiffner; Roopa Kalyanaraman; Maciej Paluch; Ben Berkhout; Paul J Maddon; William C Olson; Min Lu; John P Moore
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.

Authors:  Norbert Schülke; Mika S Vesanen; Rogier W Sanders; Ping Zhu; Min Lu; Deborah J Anselma; Anthony R Villa; Paul W H I Parren; James M Binley; Kenneth H Roux; Paul J Maddon; John P Moore; William C Olson
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  HIV-1 gp41 transmembrane oligomerization monitored by FRET and FCS.

Authors:  Sabrina Schroeder; Joshua D Kaufman; Matthias Grunwald; Peter J Walla; Nils-Alexander Lakomek; Paul T Wingfield
Journal:  FEBS Lett       Date:  2018-03-05       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.